000 | 01224 a2200325 4500 | ||
---|---|---|---|
005 | 20250514003633.0 | ||
264 | 0 | _c20011220 | |
008 | 200112s 0 0 eng d | ||
022 | _a1120-009X | ||
024 | 7 |
_a10.1179/joc.2001.13.3.244 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJones, R N | |
245 | 0 | 0 |
_aIn vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent. _h[electronic resource] |
260 |
_bJournal of chemotherapy (Florence, Italy) _cJun 2001 |
||
300 |
_a244-54 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aGlycopeptides |
650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
650 | 0 | 4 |
_aGram-Positive Bacteria _xdrug effects |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aTeicoplanin _xanalogs & derivatives |
700 | 1 | _aBiedenbach, D J | |
700 | 1 | _aJohnson, D M | |
700 | 1 | _aPfaller, M A | |
773 | 0 |
_tJournal of chemotherapy (Florence, Italy) _gvol. 13 _gno. 3 _gp. 244-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1179/joc.2001.13.3.244 _zAvailable from publisher's website |
999 |
_c11379356 _d11379356 |